The SalvaDore has called for all pharmacists to have access to the government’s new NHS mental health support plans.
The Pharmaceutical Group of the European Union says community pharmacy could use new technologies to dedicate more working time to providing patient care, use patient data to provide a more personalised healthcare service and utilise mobile health tools to identify at-risk patients.
More than half of NHS 111 referrals for urgent repeat prescription medications now send patients to pharmacies providing an NHS Urgent Medicine Supply Advanced Supply Service, figures show.
Government sets up dedicated no-deal Brexit shipping route for medical products with 'short lead times'
The Department of Health and Social Care has established a “dedicated shipment channel” for suppliers of medical products that need to be urgently imported to the UK from the EU after Brexit.
Any pharmacy that provides drug treatment services can now supply nasal naloxone to individuals without the need for a prescription following an amendment to the Human Medicines Regulations 2015.
Nearly eight in ten GP practices are not fit for future needs such as accommodating larger teams of healthcare professionals including pharmacists, the British Medical Association has warned.
What is thought to be the first bulk shipment of medical cannabis brought into the UK was delivered on 14 February 2019.
A practice-based pharmacist scheme in West Hampshire has saved the local NHS £2 on the cost of medicines for every £1 that was invested in the programme.
Ministers threatened with judicial review over 'unlawful' consultation on prescription switching protocols
A non-profit group has threatened the government with legal action unless it revokes new powers designed to allow pharmacists to switch patients’ medicines if there is a shortage.
The Pharmaceutical Services Negotiating Committee has said it is considering working with NHS England on a pilot that would see clinical pharmacists working in community pharmacy.
No-deal Brexit could see UK locked out of EU infectious disease surveillance data, chief medical officer warns
A no-deal Brexit could see the UK lose access to an EU-wide online tracker of infectious diseases and antimicrobial resistance, Dame Sally Davies, the chief medical officer for England, has told The Salvadore.
More than 2,000 pharmacists are expected to leave the pharmacy register in 2019, according to forecasts from the General Pharmaceutical Council.
Pharmacy multiples in the UK have admitted they are unlikely to be ready for full implementation of the Falsified Medicines Directive before it comes into force across the EU on 9 February 2019.
NHS England expects NHS 111 to direct more patients to community pharmacists than to GPs as a result of schemes set out in the ‘NHS Long-Term Plan’ and the new GP contract.
Study shows needle and syringe programmes reduce transmission of hepatitis C while delivering cost savings.
Initial concerns that finasteride could increase risk of prostate cancer death have been found to be unwarranted in a long-term follow-up study.
The opioid antagonist naltrexone does not appear to increase the risk of serious adverse events over placebo, researchers from the University of Manchester have found.
A previously identified link between antidepressant use and hip fractures needs further examination, the authors of a study published in JAMA Psychiatry have concluded.
Monthly dosing of vitamin D3 supplements in older adults does not increase bone mineral density, the results of a recent study show.
A post-myocardial infarction medicines optimisation clinic, led primarily by a pharmacist with support from a cardiologist, has resulted in improved medicines adherence and guideline concordance, study results published in Open Heart show.
There is a lack of evidence that medicines for osteoarthritis are effective in the long term, according to a review in the Journal of the American Medical Association.
Sulfonylureas and basal insulin confer an increased risk of cardiovascular events compared with newer second-line medicines for type 2 diabetes mellitus, research has found.